Article
Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for human leukocyte antigen B (HLA-B) genotype and allopurinol dosing: 2015 update.
Clinical pharmacology and therapeutics - 1 Jan 2016
Saito Y, Stamp L K, Caudle K E, Hershfield M S, McDonagh E M, Callaghan J T, Tassaneeyakul W, Mushiroda T, Kamatani N, Goldspiel B R, Phillips E J, Klein T E, Lee M T M
Abstract excerpt
The Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for HLA-B*58:01 Genotype and Allopurinol Dosing was originally published in February 2013. We reviewed the recent literature and concluded that none of the evidence would change the therapeutic recommendations in the original guideline; therefore, the original publication remains clinically current. However, we have updated the Supplemental...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.